| Metric | Q2 2026 | Q1 2026 | Q2 2025 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $5.2B | — | — | — | — |
| Op. Income | $592M | — | — | — | — |
| Gross Margin | 22.9% | — | — | — | — |
| Net Margin | 4.4% | — | — | — | — |
| EPS (Diluted) | $0.52 | — | — | — | — |
| Free Cash Flow | -$565M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $5.2B |
| Cost of Revenue | $4.0B |
| GROSS PROFIT | $1.2B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $595M |
| Other Expenses | $0 |
| Operating Expenses | $595M |
| Cost & Expenses | $4.6B |
| OPERATING INCOME | $592M |
| Interest Income | $22M |
| Interest Expense | $98M |
| Other Income/Expenses | -$270M |
| INCOME BEFORE TAX | $322M |
| Income Tax Expense | $75M |
| Net Income from Continuing Ops | $247M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $229M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $229M |
| D&A | $100M |
| EBIT | $442M |
| EBITDA | $542M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $5.2B |
| Cost of Revenue | $4.0B |
| GROSS PROFIT | $1.2B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $595M |
| Other Expenses | $0 |
| Operating Expenses | $595M |
| Cost & Expenses | $4.6B |
| OPERATING INCOME | $592M |
| Interest Income | $22M |
| Interest Expense | $98M |
| Other Income/Expenses | -$270M |
| INCOME BEFORE TAX | $322M |
| Income Tax Expense | $75M |
| Net Income from Continuing Ops | $247M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $229M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $229M |
| D&A | $100M |
| EBIT | $442M |
| EBITDA | $542M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $229M |
| Depreciation & Amortization | $100M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $10M |
| Other Non-Cash Items | $222M |
| Change in Working Capital | -$1.2B |
| OPERATING CASH FLOW | -$669M |
| Capital Expenditure | $104M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$8M |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$234M |
| NET CASH FROM INVESTING | -$138M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | -$1.6B |
| Common Dividends Paid | -$9M |
| Other Financing Activities | $15M |
| NET CASH FROM FINANCING | -$1.5B |
| FREE CASH FLOW | -$565M |
| Net Change in Cash | -$2.4B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $2.0B |
| Short-Term Investments | $0 |
| Net Receivables | $3.6B |
| Inventory | $828M |
| Other Current Assets | $324M |
| TOTAL CURRENT ASSETS | $6.7B |
| PP&E (Net) | $2.6B |
| Goodwill | $3.6B |
| Intangible Assets | $3.0B |
| Long-Term Investments | $1.5B |
| Tax Assets | $2.6B |
| Other Non-Current Assets | $1.5B |
| TOTAL NON-CURRENT ASSETS | $14.7B |
| TOTAL ASSETS | $21.5B |
| Account Payables | $2.4B |
| Short-Term Debt | $42M |
| Deferred Revenue | $318M |
| Other Current Liabilities | -$360M |
| TOTAL CURRENT LIABILITIES | $2.4B |
| Long-Term Debt | $7.5B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | -$369M |
| TOTAL NON-CURRENT LIABILITIES | $7.9B |
| TOTAL LIABILITIES | $10.3B |
| Common Stock | $4M |
| Additional Paid-In Capital | $7.3B |
| Retained Earnings | $3.8B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$123M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $10.9B |
| Minority Interest | $194M |
| TOTAL EQUITY | $11.1B |
| TOTAL LIABILITIES & EQUITY | $21.5B |
| Total Debt | $8.3B |
| Net Debt | $6.3B |
